M. Skelin

Most-cited papers

1. The requirements of a specialist breast centre

   L. Biganzoli, F. Cardoso, Marc Beishon, D. Cameron +23 more

   2020Breast142 citations Open access

   Semantic Scholar

   Save

2. Factors Affecting Gastrointestinal Absorption of Levothyroxine: A Review.

   M. Skelin, Tomo Lucijanić, Daniela Amidžić Klarić, A. Rešić +4 more

   2017Clinical Therapeutics120 citations

   Semantic Scholar

   Save

3. Iron Chelation in Transfusion-Dependent Patients With Low- to Intermediate-1–Risk Myelodysplastic Syndromes

   M. Lucijanić, Miran Lovrinov, M. Skelin

   2020Annals of Internal Medicine71 citations

   Semantic Scholar

   Save

4. Elevated Neutrophil-to-Lymphocyte-ratio and Platelet-to-Lymphocyte Ratio in Myelofibrosis: Inflammatory Biomarkers or Representatives of Myeloproliferation Itself?

   M. Lucijanić, D. Cicic, T. Štoos‐Veič, V. Pejsa +6 more

   2018Anticancer Research39 citations Open access

   Semantic Scholar

   Save

5. Assessing serum albumin concentration, lymphocyte count and prognostic nutritional index might improve prognostication in patients with myelofibrosis

   M. Lucijanić, Ivo Veletic, D. Rahelić, V. Pejsa +8 more

   2018Wiener Klinische Wochenschrift36 citations Open access

   Semantic Scholar

   Save

6. Effect of timing of levothyroxine administration on the treatment of hypothyroidism: a three-period crossover randomized study

   M. Skelin, Tomo Lucijanić, Ana-Marija Liberati-Čizmek, S. Klobučar +9 more

   2018Endocrine31 citations

   Semantic Scholar

   Save

7. Patients with higher body mass index treated with direct / novel oral anticoagulants (DOAC / NOAC) for atrial fibrillation experience worse clinical outcomes.

   Marko Lucijanić, Ivana Jurin, H. Jurin, Tomo Lucijanić +6 more

   2019International Journal of Cardiology30 citations

   Semantic Scholar

   Save

8. Survival analysis, more than meets the eye

   Marko Lucijanić, M. Skelin, Tomo Lucijanić

   2017Biochemia Medica22 citations Open access

   Semantic Scholar

   Save

9. Effects of antidiabetic drugs on the incidence of macrovascular complications and mortality in type 2 diabetes mellitus: a new perspective on sodium–glucose co-transporter 2 inhibitors

   D. Rahelić, E. Javor, Tomo Lucijanić, M. Skelin

   2017Annals medicus21 citations Open access

   Semantic Scholar

   Save

10. Polypharmacy, Potentially Inappropriate Medications, and Drug-to-Drug Interactions in Patients with Chronic Myeloproliferative Neoplasms

    I. Krečak, Ljerka Pivac, M. Lucijanić, M. Skelin

    2023Biomedicines16 citations Open access

    Semantic Scholar

    Save

11. Cisplatin-based chemoradiotherapy vs. cetuximab-based bioradiotherapy for p16-positive oropharyngeal cancer: an updated meta-analysis including trials RTOG 1016 and De-ESCALaTE

    P. Suton, M. Skelin, Z. Rakušić, S. Dokuzović +1 more

    2019European Archives of Oto-Rhino-Laryngology16 citations

    Semantic Scholar

    Save

12. Aspirin Use and the Risk of Cancer.

    M. Skelin, E. Javor, Marko Lucijanić

    2019JAMA Oncology11 citations

    Semantic Scholar

    Save

13. The effect of PARP inhibitors in homologous recombination proficient ovarian cancer: meta-analysis

    M. Skelin, David Šarčević, Dina Lešin Gaćina, I. Mucalo +2 more

    2022Journal of chemotherapy9 citations

    Semantic Scholar

    Save

14. The role of glucagon in the possible mechanism of cardiovascular mortality reduction in type 2 diabetes patients

    M. Skelin, E. Javor, Marko Lucijanić, Tomo Lucijanić +2 more

    2018International journal of clinical practice8 citations Open access

    Semantic Scholar

    Save

15. Evaluating ropeginterferon alfa-2b for the treatment of adults with polycythemia vera

    I. Krečak, M. Skelin, S. Verstovsek

    2023Expert Review of Hematology6 citations

    Semantic Scholar

    Save

16. Higher estimated plasma volume status may be associated with an inferior survival in patients with pulmonary embolism

    I. Krečak, Karla Nižetić, Monika Čeko, M. Skelin +1 more

    2022International Journal of Laboratory Hematology4 citations

    Semantic Scholar

    Save

17. The possible role of insulin and glucagon in patients with heart failure and Type 2 diabetes.

    M. Skelin, Marko Lucijanić, E. Javor

    2020European Heart Journal4 citations Open access

    Semantic Scholar

    Save

18. Platelet Counts and Risk of Major Bleeding With Ibrutinib.

    Marko Lucijanić, M. Skelin

    2019Clinical Lymphoma, Myeloma & Leukemia4 citations

    Semantic Scholar

    Save

19. Hematocrit to hemoglobin ratio (HHR) may improve prognostication in patients with pulmonary embolism

    I. Krečak, Monika Čeko, Karla Nižetić, Eva Čubrić +3 more

    2023Scandinavian Journal of Clinical and Laboratory Investigation3 citations

    Semantic Scholar

    Save

20. The economic impact of a clinical pharmacist’s involvement in the hospital medicines policy in a rural area

    E. Javor, A. Allouch, Josipa Osvaldić Galic, M. Skelin

    2021International journal of clinical practice3 citations

    Semantic Scholar

    Save

21. Dietary Supplement Use and Patient Outcomes in High-Risk Early-Stage Breast Cancer.

    E. Javor, Marko Lucijanić, M. Skelin

    2020Journal of Clinical Oncology3 citations

    Semantic Scholar

    Save

22. Comparison of media and academic attention of recently published positive and neutral or negative randomized cardiovascular clinical trials.

    M. Skelin, J. Katić, David Šarčević, D. Rahelić +4 more

    2022Reviews in cardiovascular medicine2 citations Open access

    Semantic Scholar

    Save

23. Immune-mediated platelet transfusion refractoriness in a severely thrombocytopenic patient with myelodysplastic syndrome successfully treated with romiplostim.

    I. Krečak, Ivana Škorić, M. Čengić, Filip Krečak +1 more

    2022Transfusion and Apheresis Science2 citations

    Semantic Scholar

    Save

24. Association of Early Palliative Care With Survival in Patients With Advanced Lung Cancer.

    M. Skelin, E. Javor, Marko Lucijanić

    2020JAMA Oncology2 citations

    Semantic Scholar

    Save

25. Risk stratification according to insulin type

    M. Skelin, Marko Lucijanić, E. Javor

    2018European Journal of Heart Failure2 citations Open access

    Semantic Scholar

    Save

26. Concurrent cisplatin-based chemoradiotherapy versus cetuximab-based bioradiotherapy for p16-positive, locally advanced oropharyngeal cancer: A meta-analysis.

    P. Suton, M. Skelin, I. Lukšić

    2018Annals of Oncology2 citations Open access

    Semantic Scholar

    Save

27. Influence of ovarian function supression on quality of life in breast cancer survivors during adjuvant endocrine therapy.

    Natalija Dedić Plavetić, Ana Dugonjic Okrosa, T. Silovski, Josipa Jovic Zlatovic +3 more

    2023Journal of Clinical Oncology1 citations Open access

    Semantic Scholar

    Save

28. Comment on Nauck et al. Effects of Liraglutide Compared With Placebo on Events of Acute Gallbladder or Biliary Disease in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events in the LEADER Randomized Trial. Diabetes Care 2019;42:1912–1920

    M. Skelin, Dario Rahelić, Petar Skelin, Marko Lucijanić

    2020Diabetes Care1 citations

    Semantic Scholar

    Save

29. Dabigatran Use Associated with Hemopericardium and Hemothorax

    J. Katić, J. Mirat, D. Rahelić, Ružica Avelini Perković +3 more

    20201 citations Open access

    Semantic Scholar

    Save

30. Second primary malignancies in myeloproliferative neoplasms and the role of aspirin

    M. Lucijanić, M. Skelin, R. Kušec

    2019Leukemia1 citations

    Semantic Scholar

    Save

31. Above What Age Should Ibrutinib Not Be Given With R-CHOP to Patients With Non-GBC DLBCL?

    M. Skelin, Marko Lucijanić, Tanja Miketic

    2019Journal of Clinical Oncology1 citations

    Semantic Scholar

    Save

32. Correction to: De-escalation in HPV-associated oropharyngeal cancer: lessons learned from the past? A critical viewpoint and proposal for future research.

    P. Suton, M. Skelin, I. Lukšić

    2026European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery0 citations Open access

    Semantic Scholar

    Save

33. Aspirin Versus LMWH for Thromboprophylaxis Following Hip or Knee Arthroplasty—Clinical Implications and Budget Impact

    E. Javor, Andrej Belančić, Patrik Javor, G. Hauser +4 more

    2025Pharmacology Research & Perspectives0 citations Open access

    Semantic Scholar

    Save

34. Correspondence on “Stability of alglucosidase alfa in 0.9% sodium chloride for enzyme replacement therapy in patients with Pompe disease: insights from enzyme activity and cellular uptake measurements” by Barzel et al

    Andrej Belančić, E. Javor, M. Skelin

    2025European Journal of Hospital Pharmacy: Science and Practice0 citations

    Semantic Scholar

    Save

35. PB2219: POLYPHARMACY AND DRUG-TO-DRUG INTERACTIONS MAY HAVE A NEGATIVE EFFECT ON SURVIVAL IN PATIENTS WITH CHRONIC MYELOPROLIFERATIVE NEOPLASMS

    I. Krečak, Ljerka Pivac, Eva Čubrić, M. Lucijanić +1 more

    2023HemaSphere0 citations Open access

    Semantic Scholar

    Save

36. PB2188: PROTON PUMP INHIBITORS ARE SAFE AND EFFECTIVE IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA TREATED WITH LOW-DOSE ASPIRIN

    I. Krečak, Ljerka Pivac, H. Holik, B. Coha +3 more

    2023HemaSphere0 citations Open access

    Semantic Scholar

    Save

37. Scurvy.

    I. Krečak, G. Babić, M. Skelin

    2022Acta dermatovenerologica Croatica : ADC0 citations

    Semantic Scholar

    Save

38. Concomitant multiple sclerosis and polycythemia vera successfully treated with glatiramer acetate

    I. Krečak, Sandra Celić-Bunikić, M. Skelin, M. Lucijanić +2 more

    2022Annals of Hematology0 citations

    Semantic Scholar

    Save

39. Therapeutic Drug Monitoring vs Standard Therapy During Maintenance Infliximab Therapy and Control of Immune-Mediated Inflammatory Diseases.

    E. Javor, G. Hauser, M. Skelin

    2022Journal of the American Medical Association (JAMA)0 citations

    Semantic Scholar

    Save

40. P-206 Association between primary tumor site of colorectal cancer and RAS/BRAF mutational status with venous thromboembolism: A retrospective-prospective cohort study from 3 Croatian oncology centers

    J. Jović Zlatović, M. Bevanda, M. Skelin, V. Telesmanić Dobrić +7 more

    2022Annals of Oncology0 citations Open access

    Semantic Scholar

    Save

41. On interactions between body mass index, type of anticoagulation and outcomes.

    Marko Lucijanić, M. Skelin, Ivana Jurin, I. Hadžibegović

    2020International Journal of Cardiology0 citations

    Semantic Scholar

    Save

42. PF340 PATIENTS WITH HIGHER BODY MASS INDEX TREATED WITH DIRECT / NON VITAMIN K DEPENDENT ANTICOAGULANTS (DOAC / NOAC) EXPERIENCE WORSE CLINICAL OUTCOMES

    Marko Lucijanić, Ivana Jurin, H. Jurin, B. Starčević +3 more

    2019HemaSphere0 citations Open access

    Semantic Scholar

    Save

43. Catheter Ablation Compared With Drug Therapy for Atrial Fibrillation.

    Marko Lucijanić, M. Skelin, Petar Skelin

    2019Journal of the American Medical Association (JAMA)0 citations

    Semantic Scholar

    Save

44. Radiotherapy plus cisplatin (CDDP) or cetuximab (C225) in human papilloma-virus (HPV)-associated oropharyngeal cancer (OPC)? A dilemma finally resolved. An updated meta-analysis

    P. Suton, M. Skelin, I. Lukšić

    2019Annals of Oncology0 citations Open access

    Semantic Scholar

    Save

45. Longer Survival With Anti-Programmed Cell Death 1 and Development of Cutaneous Toxic Effects, an Expected Association.

    M. Skelin, Marko Lucijanić

    2019JAMA Oncology0 citations

    Semantic Scholar

    Save

46. Value Based Pharmacy: Developing Qualitative Parameters for Drugs and Public Procurement.

    M. Skelin, E. Javor

    20190 citations

    Semantic Scholar

    Save

47. An observational, multicentre study on different insulin glargine U100 titration algorithms used in patients with type 2 diabetes in daily medical practice in Adriatic countries: The ADRESA study.

    Mladen Krnić, I. Marolt, M. Skelin, N. Grulović +1 more

    2019Diabetes Research and Clinical Practice0 citations

    Semantic Scholar

    Save

48. In reply to Swain et al.: Re-evaluation of updated meta-analysis including trials RTOG 1016 and De-ESCALaTE

    P. Suton, M. Skelin, Z. Rakušić, S. Dokuzović +1 more

    2019European Archives of Oto-Rhino-Laryngology0 citations

    Semantic Scholar

    Save

49. Hormone receptor expression and ribociclib activity in hormone receptor positive, human epidermal growth factor receptor 2 negative breast cancer

    E. Javor, Lejsa Jakupović, M. Skelin

    20180 citations Open access

    Semantic Scholar

    Save

50. 1070P Evaluate the role of induction chemotherapy in the treatment of stage II nasopharyngeal carcinoma in intensity modulated radiotherapy era

    P. Bossi, A. Hansen, C. Hsieh, L. Licitra +7 more

    20180 citations

    Semantic Scholar

    Save